Cargando…
Kynurenine pathway metabolites predict subclinical atherosclerotic disease and new cardiovascular events in chronic kidney disease
INTRODUCTION: Inflammation and oxidative stress contribute to the disproportionate burden of cardiovascular disease (CVD) in chronic kidney disease (CKD). Disordered catabolism of tryptophan via the kynurenine and indole pathways is linked to CVD in both CKD and dialysis patients. However, the assoc...
Autores principales: | Benitez, Trista, VanDerWoude, Elizabeth, Han, Yun, Byun, Jaeman, Konje, Vetalise Cheofor, Gillespie, Brenda W, Saran, Rajiv, Mathew, Anna V |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9494510/ https://www.ncbi.nlm.nih.gov/pubmed/36158159 http://dx.doi.org/10.1093/ckj/sfac138 |
Ejemplares similares
-
Tryptophan levels associate with incident cardiovascular disease in chronic kidney disease
por: Konje, Vetalise C, et al.
Publicado: (2020) -
Kynurenine Pathway Metabolites as Biomarkers in Alzheimer's Disease
por: Liang, Yuqing, et al.
Publicado: (2022) -
Kynurenine Pathway Metabolites in Humans: Disease and Healthy States
por: Chen, Yiquan, et al.
Publicado: (2009) -
Markers of subclinical atherosclerotic disease in HIV-infected individuals
por: Gupta, Pulin K, et al.
Publicado: (2018) -
Kynurenine pathway metabolites in migraine
por: Nicoletti, Ferdinando
Publicado: (2015)